REG-Verona Pharma PLC: Issue of Equity

* Reuters is not responsible for the content in this press release.

Mon May 11, 2009 11:21am EDT 

Verona Pharma plc                               

                                (the "Company")                                

                                Issue of Equity                                

The Company announces that it has issued 223,030 new ordinary shares of 0.1p
each in the Company ("Ordinary Shares") at 4.125p per share as consideration
for pubic relations services provided to the Company. Application has been made
for 223,030 Ordinary Shares to be admitted to trading on AIM and dealings are
expected to commence on 15 May 2009 ("Admission").

On Admission, the Company will have 215,481,355 shares in issue.

For further information please contact:

Professor Clive Page, Verona Pharma plc Tel: 07971 504 931

Adrian Kirk, WH Ireland Limited Tel: 0161 832 2174



END
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.